Tolvaptan and Abrocitinib: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 10, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Abrocitinib
Tolvaptan
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Here's what's going on. Abrocitinib (Cibinqo) can slow down a natural "pump" in your body that helps clear certain drugs. Tolvaptan (Jynarque or Samsca) is one of the drugs that pump handles. So when you take both, more tolvaptan may stay in your system than usual, which could make its effects and side effects stronger.
The good news is this concern is based mostly on how the drugs work, not on lots of real-world reports. Please don't stop or change either medicine on your own. Your care team can manage this easily by watching you a bit more closely and adjusting your dose if needed. Just let your pharmacist or doctor know you take both.
Mechanism: Abrocitinib inhibits P-glycoprotein (P-gp) mediated efflux transport. Tolvaptan is a P-gp substrate, so coadministration may increase tolvaptan exposure (AUC/Cmax). Neither agent's active moiety depends on this transporter for activation, so the effect is a straightforward increase in substrate exposure and potential toxicity.
- Direction: Increased tolvaptan exposure and pharmacodynamic effect.
- Magnitude: Not quantified.
- Onset: Unspecified.
- Evidence: Theoretical.
- Management: If coadministration is necessary, monitor appropriately (aquaretic effect, volume status, serum sodium, liver function per tolvaptan labeling) and individualize/titrate the tolvaptan dose. The original warning references narrow-therapeutic-index P-gp substrates such as digoxin.
What happens
Increased exposure of P-glycoprotein substrate
Interaction Deep Dive
Because abrocitinib inhibits P-gp, combining it with a P-gp substrate that has a narrow therapeutic index (for example, digoxin) can raise the substrate's exposure. When such coadministration cannot be avoided, apply suitable monitoring or adjust the dose of the P-gp substrate in cases where minor changes in concentration could produce serious or life-threatening toxicities1.
Why it happens (mechanism)
Inhibition of P-glycoprotein-mediated efflux transport by abrocitinib
How to manage this interaction
You can usually take both safely with a little extra oversight. Because abrocitinib may raise tolvaptan levels, here's how a care team typically handles it:
- Keep taking both medicines exactly as prescribed unless your provider tells you otherwise.
- Your team may monitor you more closely (for example, checking your sodium levels, fluid balance, and liver function, which are already tracked with tolvaptan).
- Your tolvaptan dose may need to be adjusted and individualized by your care team.
What to do: Make sure your pharmacist and prescriber know you take both drugs, and report any new or stronger side effects like excessive thirst, frequent urination, dizziness, or unusual tiredness.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Tolvaptan and Abrocitinib together?
Abrocitinib may increase tolvaptan levels by blocking a drug-clearing pump, so keep taking both as prescribed but let your care team monitor you and adjust the tolvaptan dose if needed. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Tolvaptan and Abrocitinib interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Tolvaptan and Abrocitinib interaction managed?
You can usually take both safely with a little extra oversight. Because abrocitinib may raise tolvaptan levels, here's how a care team typically handles it: Keep taking both medicines exactly as prescribed unless your provider tells you otherwise. Your team may monitor you more closely (for example, checking your sodium levels, fluid balance, and liver function, which are already tracked with tolv… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Tolvaptan or Abrocitinib need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: CIBINQO(TM) oral tablets, abrocitinib oral tablets. Pfizer Labs (per FDA), New York, NY, 2022. DailyMed
Keep reading about Abrocitinib
Keep reading about Tolvaptan
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist